Reporting, Visualization, and Modeling of Immunogenicity Data to Assess Its Impact on Pharmacokinetics, Efficacy, and Safety of Monoclonal Antibodies

The AAPS Journal
Chaitali PasseyManish Gupta

Abstract

The rapidly increasing number of therapeutic biologics in development has led to a growing recognition of the need for improvements in immunogenicity assessment. Published data are often inadequate to assess the impact of an antidrug antibody (ADA) on pharmacokinetics, safety, and efficacy, and enable a fully informed decision about patient management in the event of ADA development. The recent introduction of detailed regulatory guidance for industry should help address many past inadequacies in immunogenicity assessment. Nonetheless, careful analysis of gathered data and clear reporting of results are critical to a full understanding of the clinical relevance of ADAs, but have not been widely considered in published literature to date. Here, we review visualization and modeling of immunogenicity data. We present several relatively simple visualization techniques that can provide preliminary information about the kinetics and magnitude of ADA responses, and their impact on pharmacokinetics and clinical endpoints for a given therapeutic protein. We focus on individual sample- and patient-level data, which can be used to build a picture of any trends, thereby guiding analysis of the overall study population. We also discuss meth...Continue Reading

References

Feb 15, 2002·The New England Journal of Medicine·Nicole CasadevallPatrick Mayeux
Jul 27, 2006·Allergy·W J Pichler
Sep 1, 2007·Neurology·P A CalabresiUNKNOWN AFFIRM and SENTINEL Investigators
Jun 9, 2009·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Enno SchmidtArno Kromminga
Feb 17, 2010·Archives of Dermatology·Lidian L A LecluseGert-Jan Wolbink
Aug 27, 2010·Journal of Pharmaceutical Sciences·Satish Kumar Singh
Jun 4, 2011·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Suhrad G BanugariaPriya S Kishnani
Nov 26, 2011·Expert Review of Clinical Pharmacology·Michael G ToveyChristophe Lallemand
Mar 13, 2012·The AAPS Journal·Narendra ChirmuleBernd Meibohm
Jul 24, 2012·Journal of Crohn's & Colitis·François AubinDaniel Wendling
Aug 21, 2012·Pharmaceutical Research·Yow-Ming C WangHae-Young Ahn
Jan 2, 2013·Therapeutic Advances in Neurological Disorders·Paul I Creeke, Rachel A Farrell
Aug 8, 2013·Journal of Immunotoxicology·Kirsty D RatanjiIan Kimber
Dec 11, 2014·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Gouri S Pandey, Zuben E Sauna
Jan 30, 2016·The AAPS Journal·Boris GorovitsLi Xue
Feb 26, 2016·The AAPS Journal·Robert N Schuck, Joseph A Grillo
Mar 1, 2016·Clinical and Translational Science·K M MorrisseyS Kasichayanula
Mar 20, 2016·Journal of Pharmacokinetics and Pharmacodynamics·Leonid GibianskyManish Gupta
Apr 22, 2016·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Carlos PinedaClaudio Carini
Jul 21, 2016·Journal of Immunology Research·Anshu KuriakosePradip Nair
Sep 1, 2016·Journal of Immunology Research·Alison SmithFrank-Peter Theil
Sep 9, 2016·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Brittany A ToddSheila L Stadler
Sep 30, 2016·The Journal of International Medical Research·Alessandra VultaggioAndrea Matucci
Dec 27, 2016·CPT: Pharmacometrics & Systems Pharmacology·G BajajY Feng
Mar 2, 2017·The AAPS Journal·Daniel T MytychYanchen Zhou

❮ Previous
Next ❯

Citations

Jan 12, 2019·British Journal of Clinical Pharmacology·Erwin DreesenThomas Bouillon
Nov 11, 2020·American Journal of Clinical Dermatology·Courtney E HeronSteven R Feldman
Jan 9, 2021·The Journal of Headache and Pain·Joshua M CohenJennifer Stratton

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.